Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360123 · ClinicalTrials.gov registry record · NA
Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03360123 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 4 participants.
The verdict
NCT03360123, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will evaluate the perceptions of the effects of two anxiolytic medications commonly used during dental treatment in patients weighing 40 kilograms or more.
Interventions
- DRUG Midazolam Hydrochloride 2Mg/mL Syrup
- DRUG Triazolam 0.125 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2018-04-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03360123
The ClinicalTrials.gov registry entry for NCT03360123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam Hydrochloride 2Mg/mL Syrup is the first listed.
NCT03360123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03360123 about?
NCT03360123 is a clinical study titled "Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient". This study will evaluate the perceptions of the effects of two anxiolytic medications commonly used during dental treatment in patients weighing 40 kilograms or more.
What is the current status of trial NCT03360123?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2018-01-26. Estimated completion is 2018-04-11.
What interventions are being tested in trial NCT03360123?
The interventions under investigation include: Midazolam Hydrochloride 2Mg/mL Syrup (DRUG), Triazolam 0.125 MG (DRUG).
Who is sponsoring clinical trial NCT03360123?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.